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b-Arrestins function to mediate G protein-coupled receptor (GPCR) desensitization and internaliza-
tion and to initiate G protein independent signaling of GPCRs. Elucidating how b-arrestin and G pro-
tein signal pathways coordinate with each other is important to fully understand GPCR signaling.
Here we report that b-arrestin-1 directly interacts with Gas. Puriﬁed b-arrestin-1 binds to Gas in a
rapid association and dissociation manner. b-Arrestin-1 promotes the binding and the release of
GTPcS from Gas in vitro. b-Arrestin-1 L33K mutant shows reduced interaction with Gas and has
no detectable effects on Gas function. Our study thus reveals a direct crosstalk of b-arrestin-1 with
Gas.
Structured summary of protein interactions:
Gaq physically interacts with Beta-arrestin-1 by cross-linking study (View interaction).
Gaq physically interacts with Beta-arrestin-1 by anti tag coimmunoprecipitation (View interaction).
Gas binds to Beta-arrestin-1 by biophysical (View Interaction: 1, 2).
Gas physically interacts with Beta-arrestin-1 by anti tag coimmunoprecipitation (View interaction).
Beta-arrestin-1 physically interacts with Gas by anti bait coimmunoprecipitation (View interaction).
Gas physically interacts with Beta-arrestin-1 by cross-linking study (View interaction).
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction There are four major classes of Ga subunits including the stimula-G proteins and b-arrestins function as two primary transducers
for G protein-coupled receptors (GPCRs) and separate the majority
of GPCR signaling to two parts: the G-protein-dependent signaling
and b-arrestin-mediated signaling. Most of the GPCR ligands in-
duce both b-arrestin and G protein signaling pathways; the tight
coordination of these two signaling pathways is very important
for determining the spatiality, temporality and speciﬁcity of the
cellular response, of which the underlying molecular mecha-
nism(s) has still not been fully elucidated.
The binding of the GPCR with its ligands causes a conforma-
tional change in the GPCR and then activates its associated hetero-
trimeric G protein complexes [1]. The heterotrimeric G protein
complex consists of the Ga and tightly associated Gbc subunits.tory Gas, the inhibitory Gai/o, Gaq/11 and Ga12/13 [2]. The Ga sub-
units cycle between GTP-bound active and GDP-bound inactive
forms. There are many regulatory proteins that mediate Ga func-
tion, including GTPase-activating proteins (GAPs) [3,4], guanine
nucleotide dissociation inhibitors (GDIs) [5–8] and guanine nucle-
otide exchange factors (GEFs) [9–11]. These G protein regulators all
function through their direct physical interaction with Ga.
The binding of b-arrestins to the activated GPCRs initiates the
desensitization of G-protein-dependent signals [12] as well as the
G-protein-independent signal cascades. However, how the dual
functions of b-arrestins converge remains largely unknown.
b-Arrestins function as scaffold proteins to recruit other proteins
such as the non-receptor tyrosine kinase c-Src to the receptor [13],
which then activates mitogen-activated protein kinases (MAPK
[14–16]). Furthermore, studies have demonstrated that b-arrestins
regulate diverse signaling pathways in addition to those for GPCRs
by serving as amultiple function binding partner for various protein
complexes [17]. Interestingly, it has been reported that b-arrestins
directly bind some of the small G proteins (i.e., ARF6 and ARNO
[18]) or their regulators (i.e., ARHGAP21 [19] and Ral-GDS [20]) to
mediate their functions. Given that the small G proteins are homol-
ogous to the Ga subunit in heterotrimeric G protein, it would be
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in an interaction-dependent manner.
2. Materials and methods
2.1. Plasmids
Full length homo Ga genes were cloned into a modiﬁed pcDNA3
vector in-frame with a FLAG-tag at the N-terminus. Plasmids con-
taining cDNA encoding homo b-arrestin-1 wild type and mutants
in-frame with HA-tag at the C-terminus were generated and cloned
into the pcDNA3 vector, as previously described [21]. Bacterial
expression vectors containing His6-Sumo-TEV-tagged Ga genes
were constructed in a modiﬁed pET28a(+) vector. The GST-b-arres-
tin-1-pGEX4 construct expressing GST-tagged rattus b-arrestin-1
with a thrombin proteolysis site directly after the GST-tag was
from Dr. Jinpeng Sun (Shandong University, PRC). The authenticity
of the DNA sequences was conﬁrmed by sequencing.
2.2. Antibodies and reagents
The rabbit anti-Gas antibody (06-237) was from EMD Millipore
Corporation. Mouse anti-b-arrestin-1 antibody was from Abmart.
Rabbit anti-b-arrestin-1 (A1CT) antibodies were provided by Dr.
Robert J. Lefkowitz (Duke University Medical Center). Dithi-
obis[succinimidylpropionate] (DSP, 22586) was from Thermo.
[35S]GTPcS (NEG030H) was obtained from PerkinElmer Life Sci-
ences. Other reagents if not speciﬁed are all from Sigma.
2.3. Immunoprecipitation assay
For endogenous immunoprecipitation, HEK293T cells were
lysated with IP buffer (50 mM Tris–HCl pH7.4, 150 mM NaCl,
2 mM EDTA, 10% glycerol and 1% Triton X-100) for 30 min at
4 C. b-Arrestin-1 was immunoprecipitated using mouse anti-b-
arrestin-1 for 8 h to overnight, following incubation with a EZviewFig. 1. b-Arrestin-1 interacts with Gas. (A) b-Arrestin-1 interacts with Gas. HEK293T cells
lyzed and immunoprecipitated with anti-FLAG M2-agarose. (B) Interaction of b-arres
overexpressing FLAG-tagged Gaq, Gas, Gai or Gao with HA-tagged b-arrestin-1 were in
Interaction between endogenous b-arrestin-1 and Gas. Lysates from HEK293T cells wer
puriﬁed protein complexes were detected on western blots with anti-Gas and rabbit anred protein G afﬁnity gel for 2 h. For overexpressed FLAG-tagged
Ga, anti-FLAG M2 afﬁnity gels were used for immunopuriﬁcation.
Immunoprecipitated complexes were eluted and subjected to
Western blot. Alternatively, for crosslinking reactions, the lysates
were divided into two equal parts. 2 mM homobifunctional cleav-
able N-hydroxysuccinimide-ester DSP or DMSO was added to the
lysate. After incubation at 4 C for 30 min, the reaction was
quenched by 50 mM glycine for 10 min on ice. The lysates were
then used for immunoprecipitation.
2.4. Puriﬁcation of recombinant proteins
Ga or b-arrestin-1 was expressed in BL21 (DE3)-Codon Plus-RP
cells in the presence of 50 lg/ml kanamycin or ampicillin. The cells
were grown at 37 C in LB medium to A600 nm of 0.7 and then in-
duced with 100 lM isopropyl-b-D-thiogalactoside (IPTG, Amresco) at
16 C overnight. For the puriﬁcation of Gas, the cells were lysed in
ice-coldbufferA [50 mMTris–HCl (pH8.0), 500 mMNaCl, 1 mMEDTA,
1.1 mM MgCl2, 1 mM dithiothreitol (DTT) and 10% glycerol] using a
French press (JNBIO). The clean supernatant fraction was loaded onto
a Ni Sepharose 6 Fast Flow resin column (GE Healthcare) equilibrated
with buffer A without DTT. The protein-loaded resin was washed and
the bound protein was eluted with 800 mM imidazole. The His6-
sumo-tag was removed by TEV proteolyses and re-incubation with
Ni Sepharose 6 Fast Flow resin. Samples were further concentrated
withUltra-15Centrifugal Filter (Merck-Millipore)with a 10-kDanom-
inal molecular weight limit (NMWL) and loaded onto a Superdex 200
column (GE Healthcare) equilibrated in buffer B [20 mM Hepes (pH
8.0), 100 mM NaCl, 1 mM EDTA, 1.1 mM MgCl2 and 1mM DTT]. The
Gas-containing fractions were collected. Gai was puriﬁed using the
same process but without MgCl2. For purifying b-arrestin-1, the cells
were lysed in ice-cold buffer C [20 mM Tris–HCl (pH 8.0), 150 mM
NaCl, 1 mM EDTA, 10 mM DTT, 10% glycerol and 0.05% n-dodecyl-b-
D-maltoside (DDM)] using a French press (JNBIO). After centrifuging,
the supernatant fraction was loaded onto a glutathione superﬂow re-
sin column (QIAGEN) equilibratedwith buffer Cwithout DTT. b-Arres-overexpressing FLAG-tagged Gaq, Gas, Gai or Gao with HA-tagged b-arrestin-1 were
tin-1 with Ga in the presence of crosslinkers. Cell lysates from HEK293T cells
cubated with 2 mM DSP or DMSO and then subjected to immunoprecipitation. (C
e subjected to immunoprecipitation using mouse anti-b-arrestin-1 antibodies. The
ti-b-arrestin-1 antibodies.)
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moved the N-terminal GST-tag. The eluted protein fractions were dia-
lyzed against buffer D [20 mM Tris–HCl (pH 8.0), 50 mM NaCl, 1 mM
EDTA, 10 mM DTT, 10% glycerol and 0.01% DDM], concentrated using
a Ultra-15 Centrifugal Filter with a 30-kDa NMWL and subjected to a
Superdex 200 column (GE Healthcare) equilibrated in buffer E
[20 mM Hepes (pH 8.0), 100 mM NaCl, 1 mM EDTA, 1 mM DTT and
0.01% DDM]. The appropriate fractions were collected. The purity of
Ga and b-arrestin-1 were monitored on Coomassie Blue stained gel.
2.5. Biolayer interferometry assays
The binding kinetics and afﬁnities between Gas and b-arrestin-1
were measured using biolayer interferometry (ForteBio). All bind-
ing assays were performed at 25 C in solid-black 96-well plates
containing 200 ll of solution in each well. Streptavidin optical sen-Fig. 2. Biolayer interferometry analysis of the direct interaction between b-
arrestin-1 and Gas. (A–C) The kinetics of b-arrestin-1 binding to Gas was explored
using the ForteBio Octet Red instrument. Biotinylated Gas was loaded on the
streptavidin biosensors (SA). Puriﬁed b-arrestin-1 was incubated with Gas-loaded
SA at 25 C. The 2:1 heterogeneous ligand (HL) model was used to ﬁt the
association/dissociation steps. (D) 4 lM b-arrestin-1 was incubated with Gas-
loaded SA in the absence or the presence of 1 mM GDP or GTPcS at 25 C.sor pins (SA biosensors, ForteBio) were loaded with 50 lg/ml bio-
tinylated Gas in buffer A [20 mM Hepes (pH 8.0), 100 mM NaCl,
1 mM EDTA, 1.1 mM MgCl2 and 1 mM DTT]. The loaded biosensors
were washed in the same buffer and then transferred into buffer B
[20 mM Hepes (pH 8.0), 100 mM NaCl, 1 mM EDTA, 1 mM DTT and
0.05% DDM] as the baseline. The b-arrestin-1 was diluted in buffer
B. The association and dissociation measurements of Gas on the
biosensor to b-arrestin-1 were performed. Any baseline drift was
corrected by subtracting the shift recorded from a sensor loaded
with ligand but incubated with no analyte. The kinetic parameters
(kon and koff) and afﬁnities (KD) were calculated. Data Analysis 7.0
software (ForteBio) was used for data analysis and curve ﬁt. All
the experiments were repeated at least twice.2.6. GTPcS binding and release assays
GTPcS binding assays were performed using a ﬁlter-binding
method, as previously described [11]. The reactions of Gas and
Gai were conducted at 20 and 30 C, respectively. The indicated
dosages of b-arrestin-1 were pre-incubated in GTPcS-binding buf-
fer [20 mM Hepes pH 8.0, 100 mM NaCl, 4 mM DTT, 1 mM EDTA,
10 mMMgCl2, 0.05% (m/v) C12E10 and 10 lM [35S]GTPcS. To initi-
ate the reaction, Gas or Gai was added to a ﬁnal concentration of
100 nM. The reactions were quenched in ice-cold GTP quench buf-
fer [20 mM Tris–HCl, pH 7.7, 100 mM NaCl, 10 mM MgCl2, 1 mM
GTP and 0.08% (m/v) C12E10] and were ﬁltered onto BA-85 nitro-
cellulose ﬁlters. GTPcS release were analyzed as previously de-
scribed [11]. Brieﬂy, 100 nM Gas and indicate b-arrestin-1 were
pre-incubated in GTPcS-binding buffer for 1 h at 20 C with
10 lM [35S]GTPcS. GTPcS release from Gas was initiated at 20 C
by challenge with 100 lM non-radioactive GTPcS. Duplicated ali-
quots were collected from the reactions at the indicated time
points and were ﬁltered onto BA-85 nitrocellulose ﬁlters. The ﬁl-
ters were washed [20 mM Tris–HCl, pH 7.7, 100 mM NaCl and
2 mM MgCl2], dried and subjected to scintillation counting. The
data were ﬁt to exponential one phase association or decay func-
tions using GraphPad Prism version 5.0.
2.7. Statistical analysis
The quantitative results from at least three experiments were
expressed as the means ± S.E.M. of at least three independent
experiments. Statistical signiﬁcance was determined by an analysis
of variance (ANOVA). Differences with P values of <0.05 were con-
sidered to be statistically signiﬁcant.
3. Results
3.1. b-Arrestin-1 interacts with Gas
The cellular interaction between b-arrestin-1 and Ga subunits
were examined by immunoprecipitation assays that used hemag-
glutinin (HA)-tagged b-arrestin-1 in combination with FLAG-
tagged Gaq, Gas, Gai, or Gao. HA-b-arrestin-1 was detected in the
immunopuriﬁed FLAG-tagged Gas complex (Fig. 1A, lane 3). We
also observed a very slight amount of HA-b-arrestin-1 binding to
FLAG-Gaq (Fig. 1A, lane 2). To conﬁrm the interaction between b-
arrestin-1 and Ga subunits with minimized non-speciﬁc binding,
we crosslinked the cellular proteins prior to extraction and then
performed the immunoprecipitation in a denaturing buffer con-
taining SDS. The crosslinking reagent that we employed was the
homobifunctional cleavable N-hydroxysuccinimide-ester DSP,
which contains a 1.2-nm linker arm. The interactions between
FLAG-tagged Gaq and HA-tagged b-arrestin-1 and between FLAG-
tagged Gas and HA-tagged b-arrestin-1 were retained under a
Table 1
Kinetics of interaction between b-arrestin-1 and Gas in the absence or presence of GDP or GTPcS.a
Analyte Buffer Rate constants
Rmax Kon (M1 ts1) Koff (s1) KD (lM)
b-Arrestin-1 wt w/o GDP or GTPcS 0.2531 ± 0.0013b 1.52 ± 0.01  103c 1.38 ± 0.01  103d 0.911e
0.1864 ± 0.0013f 8.03 ± 0.24  104g 9.23 ± 0.24  102h 1.15i
0.910 ± 0.0004j
b-Arrestin-1 wt w/. GDP 0.1643 ± 0.001b 3.14 ± 0.03  103c 5.81 ± 0.14  104d 0.185e
0.1411 ± 0.0014f 3.96 ± 0.13  104g 4.26 ± 0.13  102h 1.08i
0.950 ± 0.023j
b-Arrestin-1 wt w/. GTPcS 0.1867 ± 0.0011b 1.68 ± 0.01  103c 1.73 ± 0.01  103d 1.03e
0.1589 ± 0.0011f 4.46 ± 0.10  104g 5.84 ± 0.11  102h 1.31i
1.00 ± 0.0001j
b-Arrestin-1 L33K w/o GDP or GTPcS 0.2500 ± 0.0031b 2.89 ± 0.11  104c 9.13 ± 0.30  102d 3.16e
0.2078 ± 0. 0013f 1.44 ± 0.01  103g 8.65 ± 0.14  104h 0.603i
3.20 ± 0.004j
Reported values are representative of a single experiment ± S.E. Similar results were obtained in replicate experiments.
a Ligands: puriﬁed 50 lg/ml Gas was biotinylated and immobilized on Streptavidin pins (ForteBio Inc.); analytes: puriﬁed b-arrestin-1 wild type or L33K (0.25–4 lM).
Buffer: with (w/.) or without (w/o) 1 mM GDP or GTPcS.
b Rmax1, derived from the curve ﬁtting for data with the 2:1 HL model.
c Kon1, derived from the curve ﬁtting for data with the 2:1 HL model.
d Koff1, derived from the curve ﬁtting for data with the 2:1 HL model.
e KD1, derived from the curve ﬁtting for data with the 2:1 HL model.
f Rmax2, derived from the curve ﬁtting for data with the 2:1 HL model.
g Kon2, derived from the curve ﬁtting for data with the 2:1 HL model.
h Koff2, derived from the curve ﬁtting for data with the 2:1 HL model.
i KD2, derived from the curve ﬁtting for data with the 2:1 HL model.
j KD, obtained from steady state analysis of the secondary plot. Response at equilibrium versus concentration of analyte.
Fig. 3. Leu33 in b-arrestin-1 is required for the interaction between b-arrestin-1
and Gas. (A) b-Arrestin-1 L33K shows a reduced interaction with Gas. HEK293T
cells overexpressing HA-tagged wild type (wt) or L33K mutant b-arrestin-1 with
FLAG-tagged Gas were lyzed and immunoprecipitated with anti-FLAG M2-agarose.
(B) Interaction of b-arrestin-1 L33K with Gas in the presence of crosslinkers. Cell
lysates from HEK293T cells overexpressing HA-tagged wild type (wt) or L33K b-
arrestin-1 with FLAG-tagged Gas were incubated with 2 mM DSP or DMSO and
subjected to immunoprecipitation. (C, D) Biolayer interferometry analysis of the
interaction between b-arrestin-1 L33K and Gas. 1 lM puriﬁed wild type (wt) or
L33K b-arrestin-1 was incubated with Gas-loaded pins at 25 C. The 2:1 heteroge-
neous ligand (HL) model was used to ﬁt the association/dissociation steps.
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demonstrating a close interaction between b-arrestin-1 with Gas
and Gaq. We also observed the endogenous b-arrestin-1/Gas com-
plex as shown in Fig. 1C (lane 2). Taken together, these results indi-
cate that b-arrestin-1 interacts with Gas in cells.
3.2. A direct interaction between puriﬁed b-arrestin-1 and Gas
We used biolayer interferometry to conduct a kinetic analysis of
the interaction between b-arrestin-1 and Gas (Supplementary
Fig. S1). Puriﬁed 50 lg/ml Gas was biotinylated and immobilized
on streptavidin pins (ForteBio Inc.). The pins were washed and
incubated in wells containing different concentrations of puriﬁed
b-arrestin-1 (0.25–4 lM). The association/dissociation rate
constants and the equilibrium dissociation constants of the inter-
action were obtained from the association and dissociation phases
of the curves in the absence (Fig. 2A) or presence of either GDP
(Fig. 2B) or GTPcS (Fig. 2C). All of the binding curves demonstrated
very short and fast initial association/dissociation steps followed
by association/dissociation steps that were slower and consider-
ably longer (the experimental data are represented by blue lines
and the curve ﬁtting data are indicated by red lines). Neither
GDP nor GTPcS had a signiﬁcant effect on either the association
or the dissociation steps. However, in the presence of either GDP
or GTPcS, the maximum response was reduced (0.31 or 0.35 nm vs.
0.45 nm, Fig. 2D). Non-linear least-squares ﬁtting of the experi-
mental data generated best ﬁt with a 2:1 HL model, suggesting
the existence of two binding sites; thus, two values of associa-
tion/dissociation rate constants are presented in Table 1. The ﬁt-
ting curve generated with a 1:1 HL model, in contrast, did not
match well with the experimental data, especially at the initiation
phase of the association/dissociation steps or with a high concen-
tration of b-arrestin-1 (Supplementary Fig. S3). The residual plots
that were derived from the association/dissociation curves gener-
ally demonstrated small residuals, supporting the use of the 2:1
HL ﬁtting model for the data (Supplementary Fig. S2A–C). The R2
values were above 0.98, and the X2 values were below 0.75 for
all of the ﬁts. Equilibrium dissociation constants were obtained
from the steady-state analyses (the response at equilibrium,
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in Fig. 2A–C, right panels. The single steady-state equilibrium dis-
sociation constants, KD, are presented in Table 1. These data indi-
cate that b-arrestin-1 and Gas directly interact with each other in
a manner that involves rapid associations and dissociations.
3.3. Leu33 in b-arrestin-1 is required for the interaction between b-
arrestin-1 and Gas
By applying a series of mutations of b-arrestin-1, we discovered
that a b-arrestin-1 point mutant harboring the L33K mutation
shows a reduced interaction with Gas (Fig. 3A). This result was fur-
ther conﬁrmed under denatured conditions in the presence of DSP
(Fig. 3B).Fig. 4. Gas function is regulated by the interaction of b-arrestin-1 with Gas. (A, B) The kin
b-arrestin-1. Puriﬁed Gas (100 nM) and various concentrations of b-arrestin-1 were adde
for the indicated time and the amount of Gas-bound [35S]GTPcS at each time point was q
(C) or L33K (D) b-arrestin-1. Puriﬁed Gas (100 nM) and the indicated concentration of b-a
of 10 lM [35S]GTPcS. The reactions were initiated by adding 100 lM non-radioactive GWe compare the real-time kinetic properties of the interaction
between Gas and b-arrestin-1 wild type (wt) and between Gas
and the L33K mutant. We found that the binding of b-arrestin-1
L33K to Gas possesses an association/dissociation proﬁle that is
similar to the binding proﬁle of wild type b-arrestin-1 (Fig. 3C
and Supplementary Figs. S2D, S3D). The association/dissociation
and single steady-state equilibrium dissociation constants for
these interactions were presented in Table 1. Likewise, the pres-
ence of GDP or GTPcS had no obvious effects on the association/
dissociation steps of the interaction between Gas and b-arrestin-
1 but impaired the maximum response (0.27 or 0.25 nm vs.
0.33 nm, Supplementary Fig. S4). However, as shown in Fig. 3D,
compared with b-arrestin-1 wild type, b-arrestin-1 L33K showed
a 40% reduced maximum response (0.16 nm vs. 0.27 nm).etics of GTPcS binding to Gas in the absence or presence of wild type (A) or L33K (B)
d to a reaction mixture containing 10 lM [35S]GTPcS. After being incubated at 20 C
uantiﬁed. (C, D) [35S]GTPcS release from Gas in the absence or presence of wild type
rrestin-1 were pre-incubated in GTPcS-binding buffer for 1 h at 20 C in the presence
TPcS, and Gas-bound [35S]GTPcS was measured at indicated time points.
B. Li et al. / FEBS Letters 587 (2013) 410–416 415Furthermore, compared with b-arrestin-1 wild type, b-arrestin-
1L33K has a 3.5-fold higher steady-state KD obtained from the
equilibrium response (3.20 lM vs. 0.91 lM). These results indicate
that the residue Leu33 of b-arrestin-1 is required for this
interaction.
3.4. The interaction of b-arrestin-1 with Gas regulates Gas function
To test whether the interaction of b-arrestin-1 with Gas regu-
lates the function of Gas, we monitored the kinetics of GTPcS bind-
ing to Gas. As shown in Fig. 4A, Gas bound GTPcS at a rate of
0.11 min1, as previously reported [11]. b-Arrestin-1 increased
the binding rate of GTPcS to Gas in a dose-dependent manner
(0.12–0.21 min1). The presence of puriﬁed b-arrestin-1 (100 nM)
increased this rate to 0.15 min1 and increased the maximum
amount of GTPcS that was bound to Gas (as determined through
end point stoichiometry) from 0.39 to 0.43 mol GTPcS/mol Gas.
However, an overdose of b-arrestin-1 (200 nM) reduced the end
point stoichiometry of GTPcS binding to Gas (0.43 vs. 0.34 mol
GTPcS/mol Gas). Neither the binding rate nor the end point stoichi-
ometry of Gai binding with GTPcS changes in the presence of b-
arrestin-1 (Supplementary Fig. S5). Interestingly, similarly to the
wild type b-arrestin-1, the b-arrestin-1 binding-deﬁcient L33K mu-
tant (100 nM) increased the binding rate of GTPcS to Gas but pro-
duced no effects on the end point stoichiometry (Fig. 4B). These
data indicate that the interaction of b-arrestin-1 with Gas pro-
motes the binding of GTPcS to Gas.
We also monitored the release of GTPcS from Gas. Puriﬁed Gas
was pre-incubated with [35S]GTPcS and then challenged with ex-
cess GTPcS. As shown in Fig. 4C, despite being challenged with
100 lM GTPcS, Gas retained the pre-bound [35S]GTPcS, which
was consistent with previous reports [11]. A rapid but incomplete
GTPcS release was observed in the presence of 500 nM b-arrestin-1
(Fig. 4D). However, the same amount of L33K b-arrestin-1 pro-
duced no detectable effects on the release of GTPcS from Gas
(Fig. 4D).
On the whole, our data indicate that b-arrestin-1 directly inter-
acts with Gas but not with Gai. The interaction of b-arrestin-1 with
Gas regulates the activity of Gas.
4. Discussion
In this study, we applied multiple assays to demonstrate that by
direct interaction, b-arrestin-1 promotes Gas function. We discov-
ered that residue L33 on b-arrestin-1 is required for the interaction
between b-arrestin-1 and Gas. From the current available structure
of b-arrestin-1 [22], L33 is a hydrophobic residue on the surface of
b-arrestin-1 and potentially serves as part of the docking interface
for Gas binding (Supplementary Fig. S6). Interestingly, b-arrestin-2
exhibits 84% amino acid homology with b-arrestin-1 [23] and can
also bind to Gas. However, residue K34 on b-arrestin-2 is not crit-
ical for the b-arrestin-2/Gas interaction, which hindered further
investigation (our unpublished data).
Studies have suggested that the inactive GDP-bound G protein
pre-bindsto thereceptor [24–26].Oncethe ligandbindsto therecep-
tor, the receptor will mechanically activate the G proteins, and the
activated G proteins will then bind to GTP. Interestingly, we deter-
mined that the interaction of b-arrestin-1 with Gas promotes the
binding and release of GTP from Gas. However, detailed structure-
basedstudieswillberequiredtoelucidatethetimingandmechanism
of the involvement of the b-arrestin-1/Gas complex in the G protein
activation/deactivation cycle. Furthermore, whether and how the
receptors mediate the interaction between b-arrestin-1 and Gas as
well as how b-arrestin-1/Gas complexes transduce the GPCR signals
requires further investigation.Yang et al. previously reported that C-terminus of b-arrestin-1
associates with the Gb1c2 subunits [27], whereas our study dis-
covered that Leu33 on the N-terminus of b-arrestin-1 is required
for its interaction to Gas subunits. Thus, it is not known whether
Gbc has any effects on the b-arrestin-1/Ga interaction and vice
versa, which is now under further investigation.
The four subtypes of G proteins (Gas, Gai/o, Gaq/11 and Ga12/13)
[2] are distinguished from each other by sequence homology. Most
GPCRs are capable of activating more than one Ga subtype but
demonstrate a preference for a particular Ga subtype. In addition,
previously published studies have suggested that a conformation-
speciﬁc agonism can activate different Ga subtypes via the same
receptor [28]. Interestingly, we discovered that b-arrestin-1 binds
with Gas and not Gai/o, whereas the binding of b-arrestin-1 with
Gaq is very weak. The question of whether the interaction proper-
ties that are involved in the binding of b-arrestin-1 to different Ga
subtypes contribute to the selective activation of Ga subtypes by
GPCRs and their ligands merits further investigation.
Studies have demonstrated that G proteins and b-arrestins are
the two types of primary transducers for GPCR signaling. The
majority of GPCR signaling is ultimately dependent upon the acti-
vation of G proteins. However, the phosphorylation of ligand-
bound GPCRs by GRKs and other kinases enhances the binding
afﬁnity of b-arrestins to these receptors and allows for the occur-
rence of b-arrestin-mediated signaling that is independent of G
proteins. It would be interesting to determine whether and how
the b-arrestin-1/Gas complex facilitates the convergence of G pro-
tein-dependent signals and b-arrestin-mediated signals.
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